Back to all blog posts
Feb 7, 2017
Complimentary Webinar - Canadian Pharma Update: Patent Law
Join us for a complimentary webinar on Thursday, February 9 from 9 - 10 a.m. regarding upcoming changes to the Canadian patent regime. The top 10 Canadian patent developments of concern to pharmaceutical companies will be discussed, including:
- Supreme Court of Canada considers utility requirements - defining the "Promise"
- Validity of biologic patents
- Upcoming legislative implementation of CETA, including two-year patent extensions
- Patented Medicines Prices Review Board - review of orphan drug pricing
Click here to register
Paula Bremner is a lawyer and member of Aird & Berlis LLP's Litigation Group and Intellectual Property Group. She is a registered Canadian patent and trademark agent. Paula specializes in pharmaceutical patent litigation, particularly in the context of the Patented Medicines (Notice of Compliance) Regulations.
Kimberly McManus, (Ph.D.) is a registered patent agent and member of Aird & McBurney LP. She specializes in patent protection and enforcement issues for the pharmaceutical and chemical industries.
CPD for Lawyers: 1 Substantive Hour